SREBP: A novel therapeutic target

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 1, 2013, Pages 2-10

  Xiao, Xu ^a   Song, Bao Liang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

cAMP; insulin; miRNA; SREBP; therapeutic target; vitamin A

Indexed keywords

CYCLIC AMP; INSULIN; MESSENGER RNA; RETINOL; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ANIMAL; DRUG EFFECT; GENETICS; HUMAN; LIPID METABOLISM; METABOLIC DISORDER; PHYSIOLOGY; REVIEW;

ANIMALS; CYCLIC AMP; HUMANS; INSULIN; LIPID METABOLISM; METABOLIC DISEASES; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS; VITAMIN A;

EID: 84871757651     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms112     Document Type: Review

References (84)

1. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002, 8:1211-1217. (Pubitemid 35373551)
2. Brunzell JD and Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care 1999, 22(Suppl 3): C10-13. (Pubitemid 29164911)
3. Osborne TF and Espenshade PJ. Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been. Genes Dev 2009, 23:2578-2591.
4. Goldstein JL, DeBose-Boyd RA and Brown MS. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
5. Brown MS and Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340. (Pubitemid 27220877)
6. Brown MS and Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 1999, 96:11041-11048. (Pubitemid 29487324)
7. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X and Goldstein JL, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993, 75:187-197. (Pubitemid 23306032)
8. Sato R, Yang J, Wang X, Evans MJ, Ho YK, Goldstein JL and Brown MS. Assignment of the membrane attachment, DNA binding, and transcription-al activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J Biol Chem 1994, 269:17267-17273. (Pubitemid 24204053)
9. Sato R. Sterol metabolism and SREBP activation. Arch Biochem Biophys 2010, 501:177-181.
10. Horton JD, Goldstein JL and Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131. (Pubitemid 34496588)
11. Horton JD and Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999, 10:143-150. (Pubitemid 29187097)
12. Moore KJ, Rayner KJ, Suarez Y and Fernandez-Hernando C. microRNAs and cholesterol metabolism. Trends Endocrinol Metab 2010, 21:699-706.
13. Jeon TI and Osborne TF. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 2012, 23:65-72.
14. Sun LP, Seemann J, Goldstein JL and Brown MS. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc Natl Acad Sci USA 2007, 104:6519-6526. (Pubitemid 47175534)
15. Sun LP, Li L, Goldstein JL and Brown MS. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J Biol Chem 2005, 280:26483-26490. (Pubitemid 41022245)
16. Brown AJ, Sun L, Feramisco JD, Brown MS and Goldstein JL. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 2002, 10:237-245. (Pubitemid 35007339)
17. Espenshade PJ, Li WP and Yabe D. Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER. Proc Natl Acad Sci USA 2002, 99:11694-11699. (Pubitemid 34994461)
18. Motamed M, Zhang Y, Wang ML, Seemann J, Kwon HJ, Goldstein JL and Brown MS. Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis. J Biol Chem 2011, 286:18002-18012.
19. Sever N, Yang T, Brown MS, Goldstein JL and DeBose-Boyd RA. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 2003, 11:25-33. (Pubitemid 36126588)
20. Sewter C, Berger D, Considine RV, Medina G, Rochford J, Ciaraldi T and Henry R, et al. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 2002, 51:1035-1041. (Pubitemid 34438347)
21. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R and Goldstein JL, et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002, 110:489-500. (Pubitemid 35232292)
22. Yabe D, Brown MS and Goldstein JL. Insig-2, a second endoplasmic re-ticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci USA 2002, 99:12753-12758.
23. Dong XY and Tang SQ. Insulin-induced gene: a new regulator in lipid metabolism. Peptides 2010, 31:2145-2150.
24. Burg JS and Espenshade PJ. Regulation of HMG-CoA reductase in mammals and yeast. Prog Lipid Res 2011, 50:403-410.
25. Kostova Z, Tsai YC and Weissman AM. Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol 2007, 18:770-779. (Pubitemid 350138452)
26. Jo Y and Debose-Boyd RA. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit Rev Biochem Mol Biol 2010, 45:185-198.
27. Sever N, Song BL, Yabe D, Goldstein JL, Brown MS and DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3- methylglutaryl-CoA reductase stimulated by sterols and gera-nylgeraniol. J Biol Chem 2003, 278:52479-52490. (Pubitemid 38035841)
28. Song BL, Sever N and DeBose-Boyd RA. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubi-quitination to degradation of HMG CoA reductase. Mol Cell 2005, 19:829-840. (Pubitemid 41316676)
29. Jo Y, Sguigna PV and DeBose-Boyd RA. Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 2011, 286:15022-15031.
30. Hartman IZ, Liu P, Zehmer JK, Luby-Phelps K, Jo Y, Anderson RG and DeBose-Boyd RA. Sterol-induced dislocation of 3-hydroxy-3-methylglu-taryl coenzyme A reductase from endoplasmic reticulum membranes into the cytosol through a subcellular compartment resembling lipid droplets. J Biol Chem 2010, 285:19288-19298.
31. Li S, Brown MS and Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci USA 2010, 107:3441-3446.
32. Krycer JR, Sharpe LJ, Luu W and Brown AJ. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab 2010, 21:268-276.
33. Manning BD and Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274. (Pubitemid 46962095)
34. Yellaturu CR, Deng X, Cagen LM, Wilcox HG, Mansbach CM, 2nd, Siddiqi SA and Park EA, et al. Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. J Biol Chem 2009, 284:7518-7532.
35. Owen JL, Zhang Y, Bae SH, Farooqi MS, Liang G, Hammer RE and Goldstein JL, et al. Insulin stimulation of SREBP-1c processing in trans-genic rat hepatocytes requires p70 S6-kinase. Proc Natl Acad Sci USA 2012, 109:16184-16189.
36. Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL and Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 1998, 101:2331-2339. (Pubitemid 28270427)
37. Chen G, Liang G, Ou J, Goldstein JL and Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 2004, 101:11245-11250. (Pubitemid 39038332)
38. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS and Goldstein JL. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999, 96:13656-13661.
39. DeYoung MP, Horak P, Sofer A, Sgroi D and Ellisen LW. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008, 22:239-251.
40. Tee AR, Manning BD, Roux PP, Cantley LC and Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003, 13:1259-1268. (Pubitemid 36953298)
41. Inoki K, Li Y, Xu T and Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003, 17:1829-1834. (Pubitemid 36944560)
42. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S and Griffiths JR, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008, 8:224-236.
43. Ye J and DeBose-Boyd RA. Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb Perspect Biol 2011, 3: pii: a004754.
44. Liu TF, Tang JJ, Li PS, Shen Y, Li JG, Miao HH and Li BL, et al. Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis. Cell Metab 2012, 16:213-225.
45. Punga T, Bengoechea-Alonso MT and Ericsson J. Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding. J Biol Chem 2006, 281:25278-25286. (Pubitemid 44401915)
46. Bengoechea-Alonso MT and Ericsson J. A phosphorylation cascade controls the degradation of active SREBP1. J Biol Chem 2009, 284:5885-5895.
47. Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW and Ericsson J. Control of lipid metabolism by phosphoryl-ation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab 2005, 1:379-391. (Pubitemid 43960622)
48. Cross DA, Alessi DR, Cohen P, Andjelkovich M and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789. (Pubitemid 26004411)
49. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E and Guertin DA, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011, 146:408-420.
50. Yoshikawa T, Shimano H, Amemiya-Kudo M, Yahagi N, Hasty AH, Matsuzaka T and Okazaki H, et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol 2001, 21:2991-3000. (Pubitemid 32298367)
51. Costet P, Luo Y, Wang N and Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000, 275:28240-28245.
52. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL and Sundseth SS, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997, 272:3137-3140. (Pubitemid 27066798)
53. Luo Y and Tall AR. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest 2000, 105:513-520. (Pubitemid 30127252)
54. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y and Goldstein JL, et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 2001, 98:6027-6032. (Pubitemid 32488187)
55. Repa JJ and Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000, 16:459-481. (Pubitemid 32037514)
56. Zhang Y, Breevoort SR, Angdisen J, Fu M, Schmidt DR, Holmstrom SR and Kliewer SA, et al. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 2012, 122:1688-1699.
57. Bobard A, Hainault I, Ferre P, Foufelle F and Bossard P. Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. J Biol Chem 2005, 280:199-206. (Pubitemid 40164981)
58. Hegarty BD, Bobard A, Hainault I, Ferre P, Bossard P and Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci USA 2005, 102:791-796. (Pubitemid 40282744)
59. Cruz-Garcia L, Sanchez-Gurmaches J, Gutierrez J and Navarro I. Regulation of LXR by fatty acids, insulin, growth hormone and tumor necrosis factor-alpha in rainbow trout myocytes. Comp Biochem Physiol A Mol Integr Physiol 2011, 160:125-136.
60. Tobin KA, Ulven SM, Schuster GU, Steineger HH, Andresen SM, Gustafsson JA and Nebb HI. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem 2002, 277:10691-10697. (Pubitemid 34975649)
61. 0-monophosphate/protein kinase A signalling and suppresses sterol regulatory element-binding protein-1 expression in cultured primary chicken hepatocytes. Br J Nutr 2009, 102:680-686.
62. Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, Takahashi A and Yahagi N, et al. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 2007, 282:11687-11695. (Pubitemid 47100691)
63. Lu M and Shyy JY. Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am J Physiol Cell Physiol 2006, 290: C1477-1486. (Pubitemid 43830787)
64. Ross AC. Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J Nutr 2003, 133:291S-296S. (Pubitemid 36070621)
65. Napoli JL. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1999, 1440:139-162. (Pubitemid 29424180)
66. Zhang Y, Li R, Li Y, Chen W, Zhao S and Chen G. Vitamin A status affects obesity development and hepatic expression of key genes for fuel metabolism in Zucker fatty rats. Biochem Cell Biol 2012, 90:548-557.
67. Li R, Chen W, Li Y, Zhang Y and Chen G. Retinoids synergized with insulin to induce Srebp-1c expression and activated its promoter via the two liver X receptor binding sites that mediate insulin action. Biochem Biophys Res Commun 2011, 406:268-272.
68. Roder K, Zhang L and Schweizer M. SREBP-1c mediates the retinoid-dependent increase in fatty acid synthase promoter activity in HepG2. FEBS Lett 2007, 581:2715-2720. (Pubitemid 46829116)
69. Fernandez-Hernando C, Suarez Y, Rayner KJ and Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol 2011, 22:86-92.
70. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N and Fisher EA, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
71. Marquart TJ, Allen RM, Ory DS and Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010, 107:12228-12232.
72. Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF and Leclercq IA, et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 2010, 285:33652-33661.
73. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739. (Pubitemid 34455427)
74. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S and Lindholm M, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899. (Pubitemid 351550859)
75. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M and Watts L, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006, 3:87-98.
76. Esau CC. Inhibition of microRNA with antisense oligonucleotides. Methods 2008, 44:55-60. (Pubitemid 350297990)
77. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
78. Branch AD and Rice CM. Antisense gets a grip on miR-122 in chimpanzees. Sci Transl Med 2010, 2:13ps1.
79. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ and Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010, 51:1513-1523.
80. Tang JJ, Li JG, Qi W, Qiu WW, Li PS, Li BL and Song BL. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab 2011, 13:44-56.
81. Moon YA, Liang G, Xie X, Frank-Kamenetsky M, Fitzgerald K, Koteliansky V and Brown MS, et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglycer-idemia in animals. Cell Metab 2012, 15:240-246.
82. Park SW, Moon YA and Horton JD. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J Biol Chem 2004, 279:50630-50638. (Pubitemid 39577880)
83. Costet P, Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL and Grefhorst A, et al. Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c. J Biol Chem 2006, 281:6211-6218. (Pubitemid 43847551)
84. Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D and Park SW. Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2. J Lipid Res 2008, 49:399-409. (Pubitemid 351213625)